# 🏁 S4 Optimization Closure Report

**Date:** 2026-04-10  
**Phase:** S4 - Optuna Optimization Pipeline  
**Status:** CLOSED (Ready for Paper Trading)  

## 🎯 Executive Summary
The S4 optimization phase has been successfully completed using the `s4_main_v2` study. The pipeline integrated real backtest objectives, automated acceptance gates, and statistical validation to select the most robust candidate for production (paper trading).

## 📊 Key Results
- **Trials Executed:** 600 (Optuna TPE + Pruning)
- **Top OOS Sharpe:** 1.527
- **OOS 95% CI:** [0.403, 1.057]
- **PBO Proxy:** 0.268 (**MODERATE_OVERFITTING_RISK**)
- **Selected Trial:** **431**
- **Composite Score:** 1.5022
- **Gates Status:** **PASS** (PF 3.58, Calmar 1.33, Hard Ruin 0.0, Cost Robustness: ROBUSTO)

## 🚀 Promoted Candidate (Trial 431)
```json
{
  "min_rs_percentile": 57.37778765137335,
  "max_dist_sma20": 6.6495247781116635,
  "min_rvol": 1.1149016493825001,
  "min_adr": 1.613213313949042,
  "risk_per_trade_pct": 0.026805900676805605,
  "max_exposure_pct": 0.22123548791645659,
  "use_composite_sector_scoring": false,
  "sector_top_percentile": 0.29672532058516715,
  "use_atr_stop": false,
  "atr_stop_multiplier": 1.4940389842218635,
  "atr_trailing_multiplier": 2.9820380088803273
}
```

## ⚠️ Technical Notes
- **DSR (Deflated Sharpe Ratio):** Current implementation (0.000) is considered a conservative proxy and should not be used as a hard rejection gate until S4.1 calibration.
- **PBO:** Proxy indicates a moderate risk, which is acceptable for the first paper trading phase.
- **Paper Trading Target:** Trial 431 will be deployed for a 30-day observation window.

## 📋 Artifacts
- **Optimization Data:** `outputs/optuna_s4/results_s4_main_v2_20260410_225044.json`
- **Validation OOS:** `outputs/optuna_s4/optuna_validation_oos_s4_main_v2_20260410_231550.json`
- **Promotion Report:** `outputs/optuna_s4/promotion_report_s4_main_v2_20260410.json`
- **DB Study:** `outputs/optuna_s4/s4_main_v2.db` (locally archived)

---
**Decision:** Activate paper trading with Trial 431 immediately.
